Our in vivo study revealed that the protein levels of YAP1 in liver tissue decreased markedly in cholestasis (Figures 7A,C), which may possibly be ascribed to the effect of FXR, the major nuclear receptor involved in BA metabolism (Anakk et al., 2013). The gene discussed is NR1H4; the disease is cholestasis.